Screening compound: KBPGXNDRJJJXJM-UHFFFAOYSA-N

Screening compound: KBPGXNDRJJJXJM-UHFFFAOYSA-N
Screening compound: KBPGXNDRJJJXJM-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
KBPGXNDRJJJXJM-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K284-4610

Molecular Formula

C33H35ClN4O3S (C33 H35 ClN4 O3 S)

Compound Name

N-[(2-chlorophenyl)methyl]-4-({2-[({[(4-methylphenyl)methyl]carbamoyl}methyl)sulfanyl]-4-oxo-3,4-dihydroquinazolin-3-yl}methyl)cyclohexane-1-carboxamide

IUPAC name

N-[(2-chlorophenyl)methyl]-4-({2-[({[(4-methylphenyl)methyl]carbamoyl}methyl)sulfanyl]-4-oxo-34-dihydroquinazolin-3-yl}methyl)cyclohexane-1-carboxamide

SMILES

Cc1ccc(CNC(CSC(N2CC(CC3)CCC3C(NCc(cccc3)c3Cl)=O)=Nc(cccc3)c3C2=O)=O)cc1

InChI

InChI=1S/C33H35ClN4O3S/c1-22-10-12-23(13-11-22)18-35-30(39)21-42-33-37-29-9-5-3-7-27(29)32(41)38(33)20-24-14-16-25(17-15-24)31(40)36-19-26-6-2-4-8-28(26)34/h2-13,24-25H,14-21H2,1H3,(H,35,39)(H,36,40)

InChI Key

KBPGXNDRJJJXJM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15088383

KBPGXNDRJJJXJM-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Eccentric PPI Library (11937 compounds)

GPCR Targeted Library (31838 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds
Targets:
  • GPCR
  • Phosphatases

References: we are preparing a list of scientific research reports with KBPGXNDRJJJXJM-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound KBPGXNDRJJJXJM-UHFFFAOYSA-N?
Check Price and Availability of KBPGXNDRJJJXJM-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of KBPGXNDRJJJXJM-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for KBPGXNDRJJJXJM-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for KBPGXNDRJJJXJM-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of KBPGXNDRJJJXJM-UHFFFAOYSA-N available by request